UPC

MKT CAP:$2M

Universe Pharmaceuticals Inc.

Market Cap

$2M

Healthcare·Drug Manufacturers - Specialty & Generic·🇨🇳 China·NASDAQ

Healthcare·Drug·🇨🇳·NASDAQ

Stock Price

$3.30-$0.86 (-20.67%)

Apr 22, 2026

Company Details

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic healt...

CEO

Gang Lai

IPO Date

Mar 23, 2021

Website

www.universe-pharmacy.com

Key Metrics TTM

Revenue

$41M

-43.6% YoY

Net Income

-$12M

EPS (Diluted)

-$2,381.21

Free Cash Flow

-$15M

Revenue / Share

$72.57

Gross Margin

30.3%

Operating Margin

-26.7%

Net Margin

-30.3%

FCF Margin

-37.2%

P/S

0.0x

P/E

—

Earnings Reports

FY 2025

Jan 28, 2026

$18M-22.4%EPS -$1,055.75

Q4 2025

Jan 28, 2026

$9M-14.1%EPS -$0.69

Q2 2025

Mar 30, 2025

$9M-29.0%EPS -$944.40

FY 2024

Apr 29, 2025

$23M-28.7%EPS -$1,436.12

Q4 2024

Apr 29, 2025

$10M-26.7%EPS $719.79

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 18	$7M	$3M	$2M
Q4 18	$14M	$7M	$5M
Q2 19	$8M	$3M	$2M
Q4 19	$17M	$7M	$5M
Q2 20	$15M	$7M	$5M
Q4 20	$15M	$7M	$5M
Q2 21	$24M	$12M	$10M
Q4 21	$24M	$13M	$4M
Q2 22	$24M	$14M	$3M
Q4 22	$16M	$8M	-$10M
Q2 23	$18M	$6M	$149.3K
Q4 23	$14M	$4M	-$4M
Q2 24	$13M	$3M	-$2M
Q4 24	$10M	$3M	-$6M
Q2 25	$9M	$3M	-$2M
Q4 25	$9M	$3M	-$589.2K

Valuation

Quarter	P/S	P/E
Q2 18	—	—
Q4 18	—	—
Q2 19	—	—
Q4 19	0.0x	0.2x
Q2 20	0.0x	0.1x
Q4 20	0.0x	0.1x
Q2 21	0.0x	0.1x
Q4 21	0.0x	0.1x
Q2 22	0.0x	0.1x
Q4 22	0.0x	0.7x
Q2 23	0.0x	—
Q4 23	0.0x	—
Q2 24	0.0x	—
Q4 24	0.0x	—
Q2 25	0.0x	—
Q4 25	0.0x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 18	$1M	$1M
Q4 18	$2M	$2M
Q2 19	$3M	$3M
Q4 19	$7M	$7M
Q2 20	$3M	$3M
Q4 20	$3M	$3M
Q2 21	$1M	$1M
Q4 21	-$3M	-$16M
Q2 22	$6M	$6M
Q4 22	-$8M	-$8M
Q2 23	$5M	$5M
Q4 23	-$4M	-$4M
Q2 24	-$2M	-$2M
Q4 24	-$7M	-$7M
Q2 25	$3M	$2M
Q4 25	-$8M	-$8M

Capital Expenditures

Quarter	CapEx
Q2 18	$36.3K
Q4 18	$72.5K
Q2 19	$21.6K
Q4 19	$43.2K
Q2 20	$25.9K
Q4 20	$25.9K
Q2 21	$50.9K
Q4 21	$13M
Q2 22	$55.6K
Q4 22	$38.1K
Q2 23	$646
Q4 23	$43.5K
Q2 24	$67.7K
Q4 24	$295.4K
Q2 25	$96.8K
Q4 25	$170.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q2 20	+115.4%	+115.9%
Q4 20	+7.7%	+7.9%
Q2 21	+192.4%	+150.6%
Q4 21	+42.6%	+67.7%
Q2 22	+57.6%	+111.3%
Q4 22	+3.8%	+156.3%
Q2 23	-24.0%	+24.5%
Q4 23	-41.6%	-11.0%
Q2 24	-46.8%	-32.0%
Q4 24	-36.4%	-37.0%
Q2 25	-50.4%	-37.3%
Q4 25	-37.1%	-46.9%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 18	$0	0.0%
Q4 18	$0	0.0%
Q2 19	$0	0.0%
Q4 19	$0	0.0%
Q2 20	$0	0.0%
Q4 20	$0	0.0%
Q2 21	-$4M	-15.9%
Q4 21	-$2M	-6.8%
Q2 22	-$6M	-25.8%
Q4 22	$0	0.0%
Q2 23	$0	0.0%
Q4 23	$0	0.0%
Q2 24	$0	0.0%
Q4 24	$0	0.0%
Q2 25	$0	0.0%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q2 18	$197.3K	$320.7K	$420.1K	—
Q4 18	$394.7K	$641.5K	$840.1K	—
Q2 19	$154.6K	$364.3K	$394.7K	—
Q4 19	$309.2K	$728.7K	$789.4K	—
Q2 20	$291.6K	$619.8K	$777.8K	—
Q4 20	$291.6K	$619.8K	$777.8K	—
Q2 21	$320.5K	$742.4K	$1M	—
Q4 21	$5M	$2M	$2M	—
Q2 22	$134.5K	—	$39M	—
Q4 22	$7M	$2M	—	—
Q2 23	$2M	—	—	$4M
Q4 23	$3M	—	—	$5M
Q2 24	$86.5K	—	—	$5M
Q4 24	$3M	$3M	$7M	—
Q2 25	$96.8K	—	—	$5M
Q4 25	$574.9K	—	—	$3M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 18	$6M	$0	$6M
Q4 19	$3M	$0	$3M
Q2 20	$12M	$0	$12M
Q4 20	$10M	$0	$10M
Q2 21	$36M	$0	$36M
Q4 21	$8M	$14M	$22M
Q2 22	$14M	$14M	$29M
Q4 22	$6M	$13M	$19M
Q2 23	$13M	$13M	$26M
Q4 23	$5M	$13M	$19M
Q2 24	$9M	$3M	$11M
Q4 24	$29M	$0	$29M
Q4 25	$34M	$0	$34M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 18	6K	—	—
Q4 18	6K	0.0%	—
Q2 19	6K	0.0%	—
Q4 19	6K	0.0%	—
Q2 20	6K	0.0%	0.0%
Q4 20	6K	0.0%	0.0%
Q2 21	5K	-9.6%	-9.6%
Q4 21	5K	0.0%	-9.6%
Q2 22	6K	+12.3%	+1.5%
Q4 22	6K	0.0%	+1.5%
Q2 23	6K	0.0%	+12.3%
Q4 23	6K	0.0%	+12.3%
Q2 24	6K	+2.6%	+2.6%
Q4 24	6K	0.0%	+2.6%
Q2 25	3K	-42.8%	-41.3%
Q4 25	563K	+16097.2%	+9411.0%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q2 18	—	—
Q4 18	—	—
Q2 19	—	—
Q4 19	—	—
Q2 20	—	—
Q4 20	—	—
Q2 21	—	—
Q4 21	$90.1K	263
Q2 22	$92.0K	263
Q4 22	$71.5K	223
Q2 23	$82.8K	223
Q4 23	$61.5K	225
Q2 24	$57.3K	225
Q4 24	$45.1K	225
Q2 25	$40.7K	225
Q4 25	$9	1.0M

Revenue / Employee